Search Login Register
15-keto-13,14-dihydroprostaglandin F2alpha
(PGFM)
Summary
74
relevant articles (2 outcomes,
6 trials/studies)
found for this Bio-Agent
Description:
main metabolite of PGF2alpha in plasma after allergen provoked asthma; RN given refers to (5Z,9alpha,11alpha)-isomer; structure
Also Known As:
PGFM; 13,14-dihydro-15-keto-PGF2alpha; 13,14-dihydro-15-ketoprostaglandin F; 13,14-dihydro-15-ketoprostaglandin F2alpha; 13,14-dihydro-15-oxoprostaglandin F Show All >>
Key Diseases for which 15-keto-13,14-dihydroprostaglandin F2alpha is
Relevant
-
Premature Obstetric Labor (Premature Labor)
:
1 outcome 1 study in 11 results
-
Infection
:
1 outcome in 8 results
-
Endometriosis (Adenomyosis)
:
1 outcome in 1 result
-
Retained Placenta
:
2 studies in 5 results
-
Rupture
:
1 study in 8 results
Show All >>
Drugs Related to 15-keto-13,14-dihydroprostaglandin F2alpha
-
Dinoprost
-
Dinoprostone (PGE2)
-
Oxytocin (Pitocin)
-
Prostaglandins F (PGF)
-
Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)
-
alpha-Tocopherol
-
Arachidonic Acid (Vitamin F)
-
fenprostalene
-
Progesterone
-
8-epi-prostaglandin F2alpha
Show All >>
Therapies Related to 15-keto-13,14-dihydroprostaglandin F2alpha
-
Tocolysis
-
Cardiopulmonary Resuscitation (CPR)
-
Hysterectomy
-
Induced Abortion (Induced Abortions)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.